Loading...
Loading...
SBFMW| Name | Value |
|---|---|
| Revenues | 3,939.8K |
| Cost of Revenue | 2,448.7K |
| Gross Profit | 1,491.1K |
| Operating Expense | 6,528.0K |
| Operating I/L | -5,036.9K |
| Other Income/Expense | -18,242.1K |
| Interest Income | 111.7K |
| Pretax | -23,279.0K |
| Income Tax Expense | 233.3K |
| Net Income/Loss | -23,512.3K |
Sunshine Biopharma, Inc. is a pharmaceutical and nutritional supplement company specializing in the research and development of anticancer drugs. Their flagship product, Adva-27a, is designed to treat various forms of cancer and eliminate multidrug resistant cancer cells. Additionally, the company is developing SBFM-PL4, an anti-coronavirus treatment compound. Sunshine Biopharma also offers Essential 9, a nutritional supplement tablet, and Essential Calcium-Vitamin D supplement. They generate revenue through the sale of these science-based nutritional supplements and the potential future commercialization of their anticancer and anti-coronavirus drugs.
